Concepedia

Roque Díaz

RD

Statistics

Publications

4

Citations

187

H-Index

4

Active since

2009

Affiliations

Universidad de Navarra(Current)

University of Miami

Roque Díaz is an author at Universidad de Navarra specializing in medicine, molecular oncology, and pharmacology.

ORCID

Publications per year

2009–2015

4

Publications

4

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

Roque Díaz, Paul Nguewa, Ricardo Parrondo et al. · BMC Cancer · 2010 · 86 citations · Full text

, , +17

The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

Roque Díaz, Paul Nguewa, Juan A. Díaz-González et al. · British Journal of Cancer · 2009 · 53 citations · Full text

, , +16

Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem‐like cells

Roque Díaz, Paul Nguewa, Miriam Redrado et al. · The Prostate · 2015 · 38 citations

, , +17

Id-1B, an Alternatively Spliced Isoform of the Inhibitor of Differentiation-1, Impairs Cancer Cell Malignancy Through Inhibition of Proliferation and Angiogenesis

Paul Nguewa, Irene Manrique, Roque Díaz et al. · Current Molecular Medicine · 2014 · 10 citations

, , +17

1–4 of 4